Figure 3

Kaplan-Meier survival analysis by CD133 status (n = 83). (A) The green line represents the CD133-positive group patients with a trend of worse survival than the blue line representing CD133-negative group patients (log-rank = 40.949, P = 0.000). Mean overall survival (OS) time was 42.4 months for the CD133-positive group and 73.3 months for the CD133-negative group. (B) The green line represents CD133-positive group patients with a trend of worse survival than the blue line representing CD133-negative group patients (log-rank = 39.307, P = 0.000). Mean DFS for patients was 37.1 months for the CD133-positive group and 65.6 months for the CD133-negative group.